Order Article Reprints

Lorito N, Bacci M, Smiriglia A, Mannelli M, Parri M, Comito G, Ippolito L, Giannoni E, Bonechi M, Benelli M, et al. Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib⁺. Cells. 2020; 9(3):668. https://doi.org/10.3390/cells9030668

Lorito, Nicla, Marina Bacci, Alfredo Smiriglia, Michele Mannelli, Matteo Parri, Giuseppina Comito, Luigi Ippolito, Elisa Giannoni, Martina Bonechi, Matteo Benelli, and et al. 2020. "Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib⁺" Cells 9, no. 3: 668. https://doi.org/10.3390/cells9030668

Lorito, N., Bacci, M., Smiriglia, A., Mannelli, M., Parri, M., Comito, G., Ippolito, L., Giannoni, E., Bonechi, M., Benelli, M., Migliaccio, I., Malorni, L., Chiarugi, P., & Morandi, A. (2020). Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib⁺. Cells, 9(3), 668. https://doi.org/10.3390/cells9030668